|
Product
|
CAS No.
|
ABX
Product No.
|
|
Mannose Triflate, ultra pure
|
[92051-23-5]
|
100
|
|
Mannose Triflate, ultra pure
|
[92051-23-5]
|
101
|
|
Mannose Triflate, ultra pure
|
[92051-23-5]
|
102
|
|
Mannose Triflate PLUS, ultra pure
|
[92051-23-5]
|
105
|
|
Mannose Triflate PLUS, ultra pure
|
[92051-23-5]
|
107
|
|
FDG
|
[86783-82-6] (cyclic form)
[29702-43-0] (aldehyde form)
|
1100
|
|
6-Deoxy-6-fluoro-D-glucopyranose
|
[34168-77-9] pyranoside
[4536-08-7] open-chain
|
1108
|
|
6-FDG precursor
|
[899808-81-2]
|
1109
|
|
ClDG
|
[14685-79-1]
|
1110
|
|
Glucose Triflate
|
[113544-40-4]
|
1117
|
|
MBETG
|
CAS-RN not yet assigned
|
1118
|
|
MBBTG
|
[107794-71-8]
|
1119
|
|
FDM
|
[31077-88-0]
|
1120
|
|
ACY-FDG
|
[31077-89-1]
|
1130
|
|
1,2,3,4-Tetra-O-acetyl-beta-D-glucopyranose
|
[13100-46-4]
|
1131
|
|
Me-4-FDG precursor
|
[174618-11-2]
|
1138
|
|
Talose Triflate
|
CAS-RN not yet assigned
|
1140
|
|
FDGal
|
[7226-39-3]
|
1150
|
|
DMTr-lyxothymidine
|
[112501-53-8]
|
1180
|
|
DMTr-Nosyl-lyxothymidine
|
[444717-20-8]
|
1190
|
|
Dimethoxybenzyl-FLT precursor
|
[290371-75-4]
|
1200
|
|
Anhydrothymidine-FLT precursor
|
[191474-13-2]
|
1210
|
|
FLT Ultra Pure
|
[25526-93-6]
|
1219
|
|
3′-Fluoro-thymidine (FLT)
|
[25526-93-6]
|
1220
|
|
3′-Iodo-thymidine
|
[14260-82-3]
|
1222
|
|
5′-O-Benzoyl-2,3′-anhydrothymidine
|
[70838-44-7]
|
1230
|
|
5′-O-Benzoyl-2,3′-anhydrothymidine (GMP)
|
[70838-44-7]
|
1231
|
|
3-N-Boc-5′-O-dimethoxytrityl-3′-O-nosyl-thymidine
|
[444717-23-1]
|
1240
|
|
3-N-Boc-5′-O-dimethoxytrityl-3′-O-nosyl-thymidine (GMP)
|
[444717-23-1]
|
1241
|
|
2,2′-Anhydrothymidine
|
[22423-26-3]
|
1250
|
|
2′-Fluoro-thymidine
|
[122799-38-6]
|
1260
|
|
3-N-Boc-5′-O-dimethoxytrityl-3′-fluorothymidine
|
[138685-99-1]
|
1261
|
|
DEMM
|
[93504-92-8]
|
1280
|
|
Thymidine
|
[50-89-5]
|
1290
|
|
6-Trimethylstannyl-L-DOPA
|
[143993-90-2]
|
1300
|
|
6-Trimethylstannyl-D,L-DOPA
|
CAS-RN not yet assigned
|
1302
|
|
6-Trimethylstannyl-D-DOPA
|
CAS-RN not yet assigned
|
1303
|
|
6-Fluoro-L-DOPA hydrochloride
|
[144334-59-8]
|
1310
|
|
6-Fluoro-D,L-DOPA hydrochloride
|
[102034-49-1] (free base)
|
1311
|
|
F-L-DOPA pinacol boronate precursor
|
CAS-RN not yet assigned
|
1312
|
|
DiBoc-Iodo-L-DOPA
|
[143993-89-9]
|
1320
|
|
3,4-Di-O-Pivaloyl-L-DOPA
|
[42567-91-9]
|
1328
|
|
4-O-Pivaloyl-L-DOPA Hydrochloride
|
[122769-71-5]
|
1329
|
|
4-O-Pivaloyl-L-DOPA
|
[122551-95-5]
|
1330
|
|
6-Hydroxy-D,L-DOPA
|
[21373-30-8]
|
1332
|
|
Nucleophilic F-L-DOPA precursor
|
[1159940-23-4]
|
1335
|
|
n.c.a. Nucleophilic F-L-DOPA precursor
|
CAS-RN not yet assigned
|
1336
|
|
6-Nitro-L-DOPA hydrogensulfate
|
[1261156-59-5] (free base)
|
1337
|
|
6-Nitro-Formyl-DOPA HCl
|
CAS-RN not yet assigned
|
1338
|
|
6-Fluoro-Formyl-DOPA HCl
|
CAS-RN not yet assigned
|
1339
|
|
TriBoc-L-DOPA methyl ester
|
[857502-21-7]
|
1340
|
|
TriBoc-D,L-DOPA ethyl ester
|
CAS-RN not yet assigned
|
1341
|
|
TriBoc-L-DOPA ethyl ester
|
[203398-46-3]
|
1342
|
|
TriBoc-Iodo-L-DOPA
|
[853759-55-4]
|
1350
|
|
OMFD precursor ABX004
|
CAS-RN not yet assigned
|
1363
|
|
OMFD
|
[114077-01-9]
|
1369
|
|
N-Trifluoroacetyl-3,4-dimethoxy-6-trimethylstannyl-phenethylamine
|
[170465-14-2]
|
1370
|
|
N-Trifluoroacetyl-3,4-di-tert-butoxycarbonyloxy-6-trimethylstannyl-phenethylamine
|
[170953-68-1]
|
1371
|
|
6-Fluorodopamine
|
[71144-39-3]
|
1380
|
|
NITTP
|
[150196-34-2]
|
1400
|
|
NITTP (GMP)
|
[150196-34-2]
|
1401
|
|
NITTP (GMP)
|
[150196-34-2]
|
1402
|
|
Fluoromisonidazole
|
[13551-89-8]
|
1410
|
|
Desmethylmisonidazole
|
[13551-92-3]
|
1420
|
|
FETNIM precursor
|
[163714-99-6]
|
1430
|
|
FETNIM
|
[204977-05-9]([18F]FETNIM)
|
1440
|
|
1-(2,3-Diacetyl-5-tosyl-(α-D-arabinofuranosyl)-2-nitroimidazole
|
[494775-35-8]
|
1450
|
|
1-(5-Deoxy-5-fluoro-α-D-arabinofuranosyl)-2-nitroimidazole
|
[220793-03-3]
|
1451
|
|
N-(2-Tosyloxyethyl)phthalimide
|
[5460-83-3]
|
1452
|
|
2,3,5,6-Tetrafluorophenyl-2-(2-nitroimidazol-1-yl)acetate
|
[199734-70-8]
|
1453
|
|
N-(2-Fluoroethyl)-2-(2-nitroimidazol-1-yl)acetamide
|
[199800-19-6]
|
1454
|
|
ATSM
|
[63618-91-7]
|
1455
|
|
PTSM
|
[673-68-7]
|
1456
|
|
CuATSM
|
[68341-09-3]
|
1457
|
|
NiATSM
|
[30193-04-5]
|
1459
|
|
(R)-SCH-24518 hydrochloride
|
[128145-75-5]
|
1460
|
|
(S)-SCH-24518 hydrochloride
|
[1217462-17-3]
[135556-21-7] (free base)
|
1462
|
|
SCH-23390 hydrochloride
|
[125941-87-9]
|
1464
|
|
SCH-23388 hydrochloride
|
[1217443-99-6]
[73445-63-3] (free base)
|
1466
|
|
(R)-(-)-Norapomorphine hydrobromide
|
[115017-61-3]
[478-76-2] (free base)
|
1477
|
|
(+)-Desmethyl-NNC112
|
[221132-62-3]
|
1480
|
|
(+)-NNC112
|
[125341-24-4]
|
1490
|
|
(S)-O-Desmethylraclopride hydrobromide
|
[113310-88-6]
|
1500
|
|
(R)-O-Desmethylraclopride hydrobromide
|
[113310-87-5]
|
1501
|
|
(R,S)-O-Desmethylraclopride hydrobromide
|
[857335-91-2] (free base)
|
1502
|
|
(S)-O-Desmethylraclopride
|
[119670-11-0]
|
1510
|
|
Raclopride
|
[84225-95-6]
|
1520
|
|
Tin-epidepride precursor
|
[135382-47-7]
|
1521
|
|
Epidepride
|
[107188-87-4]
|
1522
|
|
FLB 604
|
[128600-22-6]
|
1530
|
|
FLB 457
|
[107188-74-9]
|
1540
|
|
Tosyl-Fallypride
|
[166173-74-6]
|
1550
|
|
Fallypride
|
[166173-78-0]
|
1560
|
|
Tosyl-Desmethoxyfallypride
|
[713135-14-9]
|
1570
|
|
Desmethoxyfallypride
|
[166173-81-5]
|
1580
|
|
N-Mesitylenesulfonyloxy-ethyl-spiperone
|
[128584-73-6]
|
1590
|
|
Fluoroethylspiperone
|
[106114-42-5]
|
1591
|
|
D-threo-N-NPS-Ritalinic acid
|
[159701-28-7]
|
1592
|
|
D-threo-Methylphenidate hydrochloride
|
[19262-68-1]
|
1593
|
|
(R)-N-Desmethyl PK11195
|
[157809-85-3]
|
1600
|
|
(S)-PK 11195
|
[205934-45-8]
|
1609
|
|
(R)-PK11195
|
[205934-46-9]
|
1610
|
|
(R,S)-PK11195
|
[85532-75-8]
|
1611
|
|
(S)-N-Desmethyl PK11195
|
[157809-86-4]
|
1620
|
|
(R,S)-N-Desmethyl PK11195
|
[124236-61-9]
|
1640
|
|
(+)-9-MeO-HNO hydrochloride
|
[99833-85-9]
|
1642
|
|
(+)-HNO hydrochloride
|
[858517-21-2]
|
1643
|
|
(+)-PHNO hydrochloride
|
[99705-65-4]
|
1645
|
|
(+)-F-PHNO
|
[905963-70-4]
|
1646
|
|
(+)-HNO hydrochloride (GMP)
|
[858517-21-2]
|
1647
|
|
PBR28 precursor
|
[1005325-42-7]
|
1652
|
|
PBR28 standard
|
[253307-72-1]
|
1653
|
|
FEPPA precursor
|
[1095267-89-2]
|
1654
|
|
FEPPA standard
|
[1095267-90-5]
|
1655
|
|
Azidomazenil
|
[91917-65-6]
|
1680
|
|
Desmethylazidomazenil
|
[143188-51-6]
|
1681
|
|
Nitromazenil
|
[84377-97-9]
|
1690
|
|
Mazenil pinacol boronate
|
CAS-RN not yet assigned
|
1691
|
|
Desmethylflumazenil
|
[79089-72-8]
|
1700
|
|
Flumazenil
|
[78755-81-4]
|
1710
|
|
Flumazenil acid
|
[84378-44-9]
|
1720
|
|
Tosyloxyethylflumazenil
|
[676437-17-5]
|
1721
|
|
Fluoroethylflumazenil
|
[676437-19-7] ([18F]FFMZ)
|
1730
|
|
Harmol
|
[487-03-6]
|
1753
|
|
Harmine
|
[442-51-3]
|
1755
|
|
(R)-Metomidate hydrochloride
|
[66392-64-1]
|
1760
|
|
(S)-Metomidate hydrochloride
|
[66392-65-2]
|
1762
|
|
(R)-Etomidate
|
[33125-97-2]
|
1770
|
|
(R)-Desethyl-Etomidate
|
[56649-48-0]
|
1780
|
|
(S)-Desethyl-Etomidate
|
[56649-49-1]
|
1782
|
|
(R)-Fluoroethyl-Etomidate
|
[960403-07-0]
|
1790
|
|
Nitro-Altanserin
|
[139418-53-4]
|
1800
|
|
Altanserin
|
[76330-71-7]
|
1810
|
|
Nitro-Setoperone
|
[113981-16-1]
|
1820
|
|
Setoperone
|
[86487-64-1]
|
1830
|
|
MDL105725
|
[189192-18-5]
|
1840
|
|
MDL100907
|
[139290-65-6]
|
1850
|
|
MDL100151
|
[139290-69-0]
|
1860
|
|
MDL100907 tartrate salt
|
[139290-65-6] (free base)
|
1870
|
|
SB206453
|
[148702-73-2]
|
1880
|
|
SB206453 (GMP)
|
[148702-73-2]
|
1881
|
|
SB207145
|
[148702-79-8]
|
1882
|
|
MMSE
|
[177714-21-5]
|
1900
|
|
16α-Fluoroestradiol
|
[92817-10-2]
|
1910
|
|
FDHT precursor
|
[141664-05-3]
|
1916
|
|
FDHT standard
|
[141663-88-9]
|
1918
|
|
TNB-Androstanone
|
CAS-RN not yet assigned
|
1919
|
|
FFNP precursor
|
[445379-33-9]
|
1926
|
|
FFNP standard
|
[160388-33-0]
|
1928
|
|
3-O-Trityl-6-O-desmethyl-diprenorphine
|
[157891-92-4]
|
2000
|
|
Diprenorphine hydrochloride
|
[16808-86-9]
|
2010
|
|
Diprenorphine
|
[14357-78-9]
|
2020
|
|
3-O-Trityl-diprenorphine
|
[157891-91-3]
|
2030
|
|
6-O-Fluoroethyl-6-O-desmethyl-diprenorphine
|
CAS-RN not yet assigned
|
2040
|
|
6-O-Fluoroethyl-6-O-desmethyl-3-O-trityl-diprenorphine
|
CAS-RN not yet assigned
|
2050
|
|
3-O-Trityl-6-O-desmethyl-phenethyl-orvinol
|
[1187551-69-4]
|
2051
|
|
Phenethyl-orvinol
|
[14521-98-3
|
2052
|
|
6-O-(2-Fluoroethyl)-6-O-desmethyl-phenethyl-orvinol
|
CAS-RN not yet assigned
|
2053
|
|
3-O-Trityl-6-O-desmethyl-buprenorphine
|
[157891-93-5]
|
2055
|
|
Buprenorphine hydrochloride
|
[53152-21-9]
|
2056
|
|
(S)-(-)-Normethylcarbamoyl-GR 103545
|
[260992-21-0]
|
2060
|
|
(R)-(+)-Normethylcarbamoyl-GR 103545
|
[199470-02-5]
|
2061
|
|
Normethylcarbamoyl-GR 89696
|
[126766-48-1]
|
2062
|
|
GR 89696 fumarate
|
[126766-32-3]
|
2070
|
|
(R)-(-)-GR103545 fumarate
|
[126766-43-6]
|
2071
|
|
(S)-(+)-GR89696 fumarate
|
[150133-21-4]
|
2072
|
|
Acetic acid piperidin-4-yl ester hydrochloride
|
[94886-04-1]
|
2110
|
|
Acetic acid 1-methyl-piperidin-4-yl ester hydrochloride
|
[58931-63-8]
|
2120
|
|
Propionic acid piperidin-4-yl ester hydrochloride
|
[219859-83-3]
|
2130
|
|
Propionic acid 1-methyl-piperidin-4-yl ester hydrochloride
|
[64219-77-8]
|
2140
|
|
Butyric acid piperidin-4-yl ester hydrochloride
|
CAS-RN not yet assigned
|
2150
|
|
Butyric acid 1-methyl-piperidin-4-yl ester hydrochloride
|
CAS-RN not yet assigned
|
2160
|
|
L-Homocysteine
|
[6027-13-0]
|
2200
|
|
D,L-Homocysteine
|
[454-29-5]
|
2205
|
|
L-Homocysteine thiolactone hydrochloride
|
[31828-68-9]
|
2210
|
|
L-Methionine
|
[63-68-3]
|
2220
|
|
D-Methionine
|
[348-67-4]
|
2229
|
|
D,L-Methionine
|
[59-51-8]
|
2230
|
|
N-Boc-trans-4-tosyloxy-L-proline methyl ester
|
[88043-21-4]
|
2300
|
|
N-Boc-trans-4-mesyloxy-D-proline tert-butyl ester
|
CAS-RN not yet assigned
|
2301
|
|
N-Boc-cis-4-tosyloxy-L-proline methyl ester
|
CAS-RN not yet assigned
|
2310
|
|
cis-4-Fluoro-L-proline
|
[2438-57-5]
|
2320
|
|
cis-4-Fluoro-D-proline hydrochloride
|
[913820-71-0] (free amino acid)
|
2321
|
|
trans-4-Fluoro-L-proline
|
[2507-61-1]
|
2330
|
|
rac [11C]-AIB precursor
|
[115134-32-2] (S-AIB-precursor)
|
2340
|
|
S-[11C]-AIB precursor
|
[115134-32-2]
|
2342
|
|
Desmethylcar* acid
|
[186022-53-7]
|
2390
|
|
Desmethylcar*, sodium salt
|
[98598-82-4]
|
2400
|
|
Fluoroethyl-Car*
|
[904892-57-5]
|
2420
|
|
Fluoroethyl-Car* hydrochloride
|
[1007840-96-1]
|
2421
|
|
(S)-FPSPPA
|
[1283095-64-6]
|
2450
|
|
(R)-FPSPPA
|
[1283095-67-9]
|
2460
|
|
(S)-Methyl-FPSPPA
|
[1283095-70-4]
|
2470
|
|
(R)-Methyl-FPSPPA
|
[1283095-73-7]
|
2480
|
|
(R)-Desisopropylcarazolol
|
[143412-41-3]
|
2500
|
|
(S)-Desisopropylcarazolol
|
[143412-40-2]
|
2510
|
|
(R,S)-Desisopropylcarazolol
|
[72955-96-5]
|
2511
|
|
(R)-Carazolol
|
[78859-34-4]
|
2520
|
|
(S)-Carazolol
|
[78859-33-3]
|
2530
|
|
(R,S)-Carazolol
|
[57775-29-8]
|
2540
|
|
(S)-N-Desisopropylpropranolol
|
[88547-38-0]
|
2550
|
|
GB 99
|
[116784-78-2]
|
2570
|
|
GB 67
|
[116784-70-4]
|
2580
|
|
(S)-1-(2-Amino-3-nitrophenoxy)-3-tert-butylamino-propan-2-ol
|
[132059-12-2]
|
2590
|
|
4-(2-Keto-3-methyl-1-benzimidazolinyl)piperidine
|
[53786-10-0]
|
2700
|
|
Cyclopropyl-p-nitrophenyl ketone
|
[93639-12-4]
|
2750
|
|
FNMB
|
[133066-70-3]
|
2760
|
|
3-O-Benzyl-naltrindole
|
[161532-22-5]
|
2800
|
|
N-Methylnaltrindole
|
[111555-57-8]
|
2810
|
|
QNB
|
[6581-06-2]
|
2830
|
|
Me-QNB
|
[71861-83-1]
|
2840
|
|
Benzyl-14-(R,S)-tosyloxy-6-thiaheptadecanoate
|
[137564-70-6]
|
2850
|
|
14-(R,S)-Fluoro-6-thiaheptadecanoic acid
|
[137564-72-8]
|
2860
|
|
2-O-(Trifluoromethylsulfonyl)-1,3,5-tri-O-benzoyl-α-L-ribofuranose
|
[339091-18-8]
|
2869
|
|
2-O-(Trifluoromethylsulfonyl)-1,3,5-tri-O-benzoyl-α-D-ribofuranose
|
[97614-41-0]
|
2870
|
|
5-Ethyl-2,4-bis[(trimethylsilyl)oxy]pyrimidine
|
[31167-05-2]
|
2871
|
|
5-Methyl-2,4-bis[(trimethylsilyl)oxy]pyrimidine
|
[7288-28-0]
|
2872
|
|
Bis(trimethylsilyl)cytosine
|
[18037-10-0]
|
2873
|
|
L-FEAU
|
[171720-95-9]
|
2874
|
|
α-L-FEAU
|
CAS-RN not yet assigned
|
2875
|
|
FEAU
|
[83546-42-3]
|
2876
|
|
αFEAU
|
CAS-RN not yet assigned
|
2877
|
|
FMAU
|
[69256-17-3]
|
2878
|
|
αFMAU
|
[97672-34-9]
|
2879
|
|
FTRU
|
[336881-26-6]
|
2880
|
|
FTAU
|
[213136-14-2]
|
2890
|
|
FAU
|
[69123-94-0]
|
2900
|
|
FIAU
|
[69123-98-4]
|
2910
|
|
FUdR
|
[784-71-4]
|
2920
|
|
Di-THP-nosyl-AUR
|
[1000816-92-1]
|
2921
|
|
FIRU
|
[55612-21-0]
|
2922
|
|
FAC
|
[56632-83-8]
|
2930
|
|
αFAC
|
CAS-RN not yet assigned
|
2931
|
|
3′-Fluoro-2′,3′-dideoxyuridine
|
[41107-56-6]
|
2940
|
|
5-Trimethylstannyl-2′-deoxyuridine
|
[146629-34-7]
|
2948
|
|
IUdR
|
[54-42-2]
|
2949
|
|
2′-Deoxy-L-uridine
|
[31501-19-6]
|
2950
|
|
Nitro-Xeloda
|
[865474-03-9]
|
2952
|
|
Xeloda
|
[154361-50-9]
|
2953
|
|
2′,3′-Didehydro-3′-deoxythymidine
|
[3056-17-5]
|
2954
|
|
5-Fluorouracil precursor
|
[219638-33-2] (cation)
|
2958
|
|
Tosyl-FHBG
|
[206067-84-7]
|
2960
|
|
FHBG
|
[206067-83-6]
|
2970
|
|
N,O-Di-Boc-2-TMSn-L-tyrosine ethyl ester
|
[400885-40-7]
|
3000
|
|
2-Fluoro-tyrosine
|
[78709-81-6]
|
3010
|
|
2-Iodo-tyrosine
|
[78853-38-0]
|
3020
|
|
Thyronamine Hydrochloride
|
[5221-18-1]
|
3035
|
|
3-Iodothyronamine Hydrochloride
|
[788824-64-6]
|
3036
|
|
TET
|
[478037-15-9]
|
3050
|
|
TET (GMP)
|
[478037-15-9]
|
3051
|
|
TET (GMP)
|
[478037-15-9]
|
3052
|
|
FET hydrochloride
|
[854750-33-7] (free base)
|
3061
|
|
D-FET hydrochloride
|
[223463-90-9] (free base)
|
3071
|
|
(L)-HET hydrochloride
|
[481052-68-0] (free base)
|
3081
|
|
N-Trifluoroacetyl-5-acetoxy-2-trimethylstannyl-phenylalanine ethyl ester
|
[148613-10-9]
|
3100
|
|
N,O-Di-Boc-2-TMSn-m-tyrosine ethyl ester
|
[845882-24-8]
|
3110
|
|
2-Fluoro-m-Tyrosine
|
[148613-12-1]
|
3130
|
|
2-Iodo-α-methyl-p-tyrosine
|
CAS-RN not yet assigned
|
3180
|
|
3-Iodo-α-methyl-p-tyrosine
|
[4298-17-3]
|
3190
|
|
(S)-tert-Butyl 2-((tert-butoxycarbonyl) amino)-4-Iodobutanoat
|
[161370-66-7]
|
3191
|
|
WAY 100634
|
[155204-28-7]
|
3200
|
|
WAY 100635
|
[146714-97-8]
|
3210
|
|
Desmethyl-WAY100635
|
[146715-34-6]
|
3220
|
|
Desmethyl-WAY 100634
|
[146714-76-3]
|
3230
|
|
Nitro-MPPF
|
[155204-27-6]
|
3240
|
|
MPPF
|
[155204-26-5]
|
3250
|
|
Desmethyl-MPT
|
[874471-23-5]
|
3260
|
|
MPT
|
[179756-59-3]
|
3270
|
|
TAP
|
[213766-21-3]
|
3300
|
|
IAP
|
[213764-92-2]
|
3310
|
|
Nitro-AP
|
[209530-92-7]
|
3320
|
|
FAP tartrate
|
[209530-93-8] (free base)
|
3340
|
|
TMA-AP
|
[233766-75-1]
|
3350
|
|
(-)-Flubatine standard
|
[845642-53-7]
|
3351
|
|
(-)-Flubatine precursor
|
[1421915-93-6]
|
3353
|
|
(-)-Flubatine precursor (GMP)
|
[1421915-93-6]
|
3354
|
|
(+)-Flubatine standard
|
[845642-52-6]
|
3355
|
|
(+)-Flubatine precursor
|
CAS-RN not yet assigned
|
3357
|
|
(+)-Flubatine precursor (GMP)
|
CAS-RN not yet assigned
|
3358
|
|
ASEM precursor
|
[1456877-71-6]
|
3371
|
|
Metaraminol (free base)
|
[54-49-9]
|
3380
|
|
Metaraminol bitartrate
|
[33402-03-8]
|
3390
|
|
MHED hydrochloride
|
[24493-89-8]
|
3400
|
|
Desmethyl-GR 205171
|
[180574-25-8]
|
3500
|
|
GR 205171
|
[168266-90-8]
|
3510
|
|
Desmethyl-GR 205171 Dihydrochloride
|
[262598-97-0]
|
3520
|
|
GR 205171 Dihydrochloride
|
[168266-51-1]
|
3530
|
|
Desmethyl-CNS 5161
|
[160754-78-9]
|
3540
|
|
CNS 5161
|
[160754-76-7]
|
3550
|
|
Desmethyl ABP688
|
[849469-03-0]
|
3560
|
|
Desmethyl ABP688 (GMP)
|
[849469-03-0]
|
3561
|
|
ABP688
|
[924298-51-1]
|
3570
|
|
FPEB precursor
|
[1031370-96-3]
|
3571
|
|
FPEB standard
|
[864063-10-5]
|
3572
|
|
ISOM
|
[945992-43-8]
|
3590
|
|
ISOF
|
[851705-46-9]
|
3591
|
|
Desmethyl-SCH-442416
|
[188112-92-7]
|
3700
|
|
SCH-442416
|
[316173-57-6]
|
3710
|
|
Desmethyl-MK-8278
|
[879368-41-9]
|
3720
|
|
CPTPX
|
[478173-67-0]
|
3750
|
|
CPFPX
|
[200557-18-2]
|
3751
|
|
(-)-2-beta-Carbomethoxy-3-beta-(4-fluorophenyl)tropane
|
[50370-56-4]
|
4000
|
|
(-)-2-beta-Carbomethoxy-3-beta-(4-fluorophenyl)nortropane
|
[127648-30-0]
|
4020
|
|
(-)-2-beta-Carbomethoxy-3-beta-(4-iodophenyl)tropane
|
[135416-43-2]
|
4030
|
|
TMS-CT
|
[158111-10-5]
|
4040
|
|
TBS-CT
|
[136794-88-2]
|
4041
|
|
(-)-2-beta-Carbomethoxy-3-beta-(4-iodophenyl)nortropane
|
[136794-87-1]
|
4050
|
|
(-)-2-beta-Carbomethoxy-3-beta-(phenyl)tropane
|
[50372-80-0]
|
4060
|
|
CITFES
|
[180045-77-6]
|
4100
|
|
CITFE
|
[155798-01-9]
|
4110
|
|
CITTP Tosylate
|
[186381-39-5] (free base)
|
4122
|
|
CITFP
|
[155797-99-2]
|
4130
|
|
TBSCT-FP
|
[479642-48-3]
|
4132
|
|
beta-CIT acid
|
[141807-58-1]
|
4140
|
|
2-FE-beta-CIT
|
[398497-81-9]
|
4150
|
|
PE2I acid
|
[311351-26-5]
|
4160
|
|
PE2I tin precursor
|
[188680-65-1]
|
4165
|
|
PE2I
|
[188680-71-9]
|
4170
|
|
TEO-PE2I
|
[1391711-43-5]
|
4172
|
|
FE-PE2I
|
[949091-68-3]
|
4173
|
|
Nor-beta-CClT
|
[146725-33-9]
|
4180
|
|
FECNT
|
[281667-94-5]
|
4190
|
|
Altropane acid
|
[335104-67-1]
|
4200
|
|
Altropane acid hydrochloride
|
[335104-67-1] (Altropane acid free amine)
|
4201
|
|
Altropane
|
[180468-34-2]
|
4210
|
|
Altropane hydrochloride
|
[180468-34-2] (free base)
|
4211
|
|
Norbenztropine
|
[28404-87-7]
|
4230
|
|
Benztropine Mesylate
|
[132-17-2]
|
4231
|
|
MASB
|
[296774-10-2]
|
4300
|
|
MASB (GMP)
|
[296774-10-2]
|
4301
|
|
DASB
|
[627490-01-1]
|
4310
|
|
DASB (GMP)
|
[627490-01-1]
|
4311
|
|
AFM precursor
|
[844699-84-9] (free base)
|
4320
|
|
AFM standard
|
[627490-40-8] (free base)
|
4330
|
|
(+)-McN 5652 Thiobutyrate
|
[167548-65-4] (free base)
|
4360
|
|
(+)-McN 5652
|
[259145-56-7]
[103729-16-4] (free base)
|
4370
|
|
(-)-McN 5652
|
[262352-33-0]
[103729-13-1] (free base)
|
4380
|
|
(+)-Fluoromethyl-McN 5652
|
[432038-21-6] (free base)
|
4381
|
|
FBAM precursor
|
[937025-28-0]
|
4383
|
|
FBAM standard
|
[937025-29-1]
|
4384
|
|
CPTMA
|
[124915-01-1]
|
4385
|
|
CMTMA
|
[51570-69-5] (CMTMA cation)
|
4386
|
|
TBAB
|
[660845-84-1]
|
4389
|
|
PMBAB
|
[223699-69-2]
|
4390
|
|
FB precursor
|
[124915-06-6]
|
4391
|
|
SFB
|
[66134-67-6]
|
4392
|
|
[18F]FPyBrA/[18F]FPyME precursor
|
[640749-64-0]
|
4393
|
|
FPyME standard
|
[640749-61-7]
|
4394
|
|
[18F]FPyKYNE precursor
|
[1161009-68-2]
|
4396
|
|
FPyKYNE
|
[1161009-63-7]
|
4397
|
|
FBEM precursor
|
[146474-00-2]
|
4398
|
|
FBEM standard
|
[1089194-09-1]
|
4399
|
|
(2S,3S)-N-Boc-norethylreboxetine
|
[754988-84-6]
|
4400
|
|
(2S,3S)-N-Boc-carboxylreboxetine
|
[1016545-04-2]
|
4402
|
|
(2S,3S)-Carboxylreboxetine fluoroethyl ester trifluoroacetate
|
CAS-RN not yet assigned
|
4403
|
|
Methylreboxetinecarboxylate
|
[1016545-13-3] (free base)
|
4405
|
|
(2S,3S)-Methylreboxetine
|
[105018-14-2]
|
4406
|
|
(2S,3S)-Desethylreboxetine
|
[252570-31-3]
|
4407
|
|
Norbinaltorphimine dihydrochloride
|
[113158-34-2]
[105618-26-6] (free base)
|
4500
|
|
(-)-TEBV
|
[153215-71-5]
|
4600
|
|
(-)-FEBV
|
[153215-70-4]
|
4610
|
|
(±)-9-O-Desmethyl-α-dihydrotetrabenazine
|
[5220-98-4]
|
4700
|
|
(+)-9-O-Desmethyl-α-dihydrotetrabenazine
|
CAS-RN not yet assigned
|
4710
|
|
(-)-9-O-Desmethyl-α-dihydrotetrabenazine
|
CAS-RN not yet assigned
|
4720
|
|
(±)-α-Dihydrotetrabenazine
|
[3466-75-9]
|
4730
|
|
(±)-beta-Dihydrotetrabenazine
|
CAS-RN not yet assigned
|
4731
|
|
(±)-Tetrabenazine
|
[58-46-8]
|
4732
|
|
(±)-9-O-Desmethyl-tetrabenazine
|
[149183-89-1]
|
4733
|
|
Aminothiadiazine
|
[319002-53-4]
|
4900
|
|
Chlorothiadiazine
|
[194086-61-8]
|
4910
|
|
DMTEAN
|
[259739-02-1]
|
5000
|
|
DFEAN
|
[1161260-63-4] ([18F]DFEAN)
|
5010
|
|
DMEAN
|
[259739-01-0]
|
5020
|
|
DMFEAN
|
[590365-47-2]
|
5030
|
|
6-OH-BTA-0
|
[178804-18-7]
|
5100
|
|
6-OH-BTA-0 (GMP)
|
[178804-18-7]
|
5101
|
|
6-MOMO-BTA-0
|
[566170-03-4]
|
5110
|
|
6-MOMO-BTA-0 (GMP)
|
[566170-03-4]
|
5111
|
|
6-OH-BTA-1 hydrochloride
|
CAS-RN not yet assigned
|
5120
|
|
6-MeO-BTA-0
|
[43036-17-5]
|
5130
|
|
6-OH-BTA-1 (free base)
|
[566169-93-5]
|
5140
|
|
6-O-Tosyloxyethyl-CBT
|
[1392498-16-6]
|
5149
|
|
[18F]Lansoprazole Precursor
|
[1613520-76-5]
|
5150
|
|
Astemizole
|
[68844-77-9]
|
5165
|
|
O-Desmethyl Astemizole
|
[73736-50-2]
|
5166
|
|
Desmethyl-PD 153035
|
[295330-61-9]
|
5200
|
|
PD 153035
|
[153436-54-5]
|
5210
|
|
Norverapamil
|
[67018-85-3]
|
5600
|
|
(-)-Norverapamil
|
[123931-31-7]
|
5620
|
|
(+)-Verapamil hydrochloride
|
[38176-02-2]
|
5630
|
|
N-Demethylrifampicin
|
[13292-45-0]
|
5700
|
|
Rolipram
|
[61413-54-5]
|
6000
|
|
(S)-(+)-Rolipram
|
[85416-73-5]
|
6010
|
|
(R)-(-)-Rolipram
|
[85416-75-7]
|
6020
|
|
Desmethyl-Rolipram
|
[150519-28-1]
|
6030
|
|
(S)-(+)-Desmethyl-Rolipram
|
[347148-60-1]
|
6040
|
|
(R)-(-)-Desmethyl-Rolipram
|
[347148-59-8]
|
6050
|
|
Dimethylaminoethanol
|
[108-01-0]
|
6100
|
|
Fluoroethylcholine tosylate
|
[479407-07-3]
|
6120
|
|
Fluoromethylcholine chloride
|
[459424-38-5]
|
6130
|
|
Fluoromethylcholine bromide
|
CAS-RN not yet assigned
|
6140
|
|
Bromocholine bromide
|
[28508-20-5]
|
6141
|
|
Choline chloride
|
[67-48-1]
|
6150
|
|
Fluoroethylcholine chloride
|
[479407-08-4]
|
6160
|
|
Choline iodide
|
[17773-10-3]
|
6170
|
|
DMMB
|
[40968-70-5]
|
6173
|
|
BHTMEDA
|
[60168-37-8]
|
6174
|
|
Dibromoethane
|
[106-93-4]
|
6175
|
|
Dibromomethane
|
[74-95-3]
|
6176
|
|
Bis(tosyloxy)methane
|
[24124-59-2]
|
6177
|
|
1,2-Bis(nosyloxy)ethane
|
[25297-82-9]
|
6179
|
|
1,2-Bis(tosyloxy)ethane
|
[6315-52-2]
|
6180
|
|
2-Bromoethyl nosylate
|
[52331-22-3]
|
6181
|
|
2-Bromoethyl triflate
|
[103935-47-3]
|
6182
|
|
2-Bromoethyl tosylate
|
[19263-21-9]
|
6183
|
|
2-Fluoroethyl tosylate
|
[383-50-6]
|
6184
|
|
Bis(tosyl)-1,4-butanediol
|
[4724-56-5]
|
6185
|
|
1,4-Bis(tosyloxy)but-2-yne
|
[6337-59-3]
|
6186
|
|
3-Fluoropropyltosylate
|
[312-68-5]
|
6190
|
|
1,3-Propane-di-tosylate
|
[5469-66-9]
|
6191
|
|
Fluoromethyl tosylate
|
[114435-86-8]
|
6194
|
|
Ethyl (p-tosyloxy)acetate
|
[39794-75-7]
|
6200
|
|
Potassium fluoroacetate
|
[23745-86-0]
|
6210
|
|
Sodium fluoroacetate
|
[62-74-8]
|
6211
|
|
DBCO-SCN
|
CAS-RN not yet assigned
|
6221
|
|
1-Tosyloxy-3-butyne
|
[23418-85-1]
|
6301
|
|
1-Tosyloxy-4-pentyne
|
[77758-50-0]
|
6302
|
|
1-Tosyloxy-5-hexyne
|
[76911-01-8]
|
6303
|
|
Tosyl-propargyl-diethylene glycol
|
[1119249-30-7]
|
6305
|
|
Tosyl-propargyl-triethylene glycol
|
[888009-94-7]
|
6307
|
|
Fluoro-propargyl-triethylene glycol
|
[1003005-81-9] ([18F]Fluoro-propargyl-triethylene glycol)
|
6308
|
|
3-(4-Azidophenoxy)propyl methansulfonate
|
[943726-04-3]
|
6320
|
|
(S)-O-Tosyl-1,2-Epoxybutanol
|
[91111-12-5]
|
6351
|
|
Dimethyl-8-acetyl-hexahydropyrrolo[2,3]indol-1,2-dicarboxylate
|
[79465-83-1]
|
6500
|
|
α-Methyl-L-tryptophan
|
[16709-25-4]
|
6510
|
|
Dimethyl-8-phenylsulfonyl-5-phenylsulfonyloxy-hexahydropyrrolo[2,3]indol-1,2-dicarboxylate
|
[150804-39-0]
|
6520
|
|
5-FEHTP hydrochloride
|
[1215091-03-4] (free base)
|
6532
|
|
MIBG Hemisulfate
|
[87862-25-7]
[80663-95-2] (free base)
|
7000
|
|
MIBG Hemisulfate (GMP)
|
[87862-25-7]
|
7001
|
|
MTMSBG
|
[143773-92-6] (free base)
|
7010
|
|
TMSnBG
|
[1000875-21-7]
|
7012
|
|
SGMIB Standard
|
[344791-53-3] (free base)
|
7014
|
|
SGMIB Precursor
|
[344791-59-9]
|
7015
|
|
CNS 1261
|
[341032-67-5]
|
7020
|
|
TBS-CNS 1261
|
[765890-24-2]
|
7030
|
|
MFBG pinacol boronate precursor
|
CAS-RN not yet assigned
|
7033
|
|
MFBG hydrochloride
|
[1246547-53-4]
|
7034
|
|
Mebrofenin
|
[78266-06-5]
|
7050
|
|
Disofenin
|
[65717-97-7]
|
7060
|
|
Succinimidyl-N-Boc-Hynic
|
[133081-26-2]
|
7080
|
|
Succinimidyl-Hynic hydrochloride
|
[133081-27-3]
[167639-20-5] (free base)
|
7090
|
|
S-Benzoyl-MAG-3
|
[103725-47-9]
|
7100
|
|
MAG 3
|
[66516-09-4]
|
7110
|
|
(Benzoylmercapto)acetic acid
|
[6398-74-9]
|
7111
|
|
BMEDA
|
[93798-62-0]
|
7150
|
|
MDP
|
[1984-15-2]
|
7160
|
|
HMDP
|
[14255-61-9]
|
7161
|
|
EDTMP
|
[1429-50-1]
|
7165
|
|
MIBI
|
[109434-22-2]
|
7200
|
|
Copper tetraMIBI tetrafluoroborate [Cu(MIBI)4]BF4
|
[103694-84-4]
|
7210
|
|
Copper tetraMIBI tetrafluoroborate (GMP)
|
[103694-84-4]
|
7211
|
|
Zinc-TBI
|
[104676-71-3]
|
7220
|
|
EC
|
[14344-48-0]
|
7250
|
|
ECD
|
[14344-58-2]
[121251-02-3] (free base)
|
7260
|
|
TFP-N-sucDf-Fe
|
[676596-40-0]
|
7270
|
|
TACN
|
[58966-93-1]
|
7281
|
|
PrP9
|
[1242003-07-1] (water free compound)
|
7284
|
|
Cyclen
|
[294-90-6]
|
7290
|
|
DOTA
|
[60239-18-1]
|
7300
|
|
DOTAEt
|
[137076-50-7]
|
7301
|
|
Tetrofosmin
|
[127502-06-1]
|
7310
|
|
Disodium sulfosalicylate
|
[56343-01-2]
|
7312
|
|
BPAMD
|
[872469-60-8]
|
7320
|
|
HBED-CC-tris(tBu)ester
|
CAS-RN not yet assigned
|
7330
|
|
HBED-CC-di(tBu)ester
|
CAS-RN not yet assigned
|
7331
|
|
TRODAT
|
[189950-11-6] (free base)
|
7400
|
|
S-(-)-BZM
|
[84226-04-0]
|
7500
|
|
S-(-)-IBZM
|
[84226-06-2]
|
7510
|
|
Gallium Citrate (complex)
|
CAS-RN not yet assigned
|
7520
|
|
16-Iodohexadecanoic acid
|
[2536-36-9]
|
7600
|
|
Cryptand 222
|
[23978-09-8]
|
800
|
|
Lithium Aluminium Hydride in THF bulk
|
[16853-85-3]
|
801
|
|
Lithium aluminium hydride (0.1 M in THF)
|
[16853-85-3]
|
802
|
|
Lithium aluminium hydride (0.25 M in THF)
|
[16853-85-3]
|
803
|
|
Lithium aluminium hydride (0.05 M in THF)
|
[16853-85-3]
|
804
|
|
Tetrabutylammonium Hydrogen Carbonate (0.075 M) – Aqueous solution, stabilized with ethanol
|
[17351-62-1]
|
808
|
|
Pentadecylmagnesium bromide 0.5 M in diethyl ether
|
[78887-70-4]
|
831
|
|
Lithium aluminium hydride (0.1 M in THF)
|
[16853-85-3]
|
832
|
|
Fmoc-Lys(ivDde)-OH
|
[204777-78-6]
|
9500
|
|
PMPA
|
[173039-10-6]
|
9510
|
|
Ubiquicidin (29-41) acetate
|
[216867-99-1] (net peptide)
|
9600
|
|
DOTA-Ubiquicidin (29-41) acetate
|
CAS-RN not yet assigned
|
9601
|
|
Scrambled Ubiquicidin (29-41)
|
CAS-RN not yet assigned
|
9602
|
|
NOTA-Ubiquicidin (29-41) acetate
|
CAS-RN not yet assigned
|
9603
|
|
DOTATOC (GMP)
|
[204318-14-9]
|
9702
|
|
Ga-DOTA-TOC acetate
|
[293295-70-2]
|
9703
|
|
Y-DOTA-TOC
|
[293295-66-6]
|
9704
|
|
Lu-DOTA-TOC
|
[321835-55-6] ([177Lu]-DOTA-TOC)
|
9705
|
|
DOTA-NOC acetate
|
[619300-53-7] (net peptide)
|
9712
|
|
AMBA acetate
|
[721937-56-0] (net peptide)
|
9714
|
|
DOTA-[Pro1,Tyr4]bombesin (1-14)
|
[593287-40-2] (net peptide)
|
9715
|
|
DOTA-NOC acetate (GMP)
|
[619300-53-7] (net peptide)
|
9716
|
|
Ga-DOTA-NOC
|
[1027785-95-0]
[1040397-47-4] [68Ga]DOTA-NOC
|
9717
|
|
NODAGA-NOC acetate
|
CAS-RN not yet assigned
|
9718
|
|
HYNIC-TOC trifluoroacetate
|
[257943-19-4] (net peptide)
|
9721
|
|
HYNIC-NOC trifluoroacetate
|
CAS-RN not yet assigned
|
9730
|
|
Pentreotide trifluoroacetate
|
[138661-02-6] (net peptide)
|
9740
|
|
DTPA-TOC trifluoroacetate
|
[147790-81-6] (net peptide)
|
9744
|
|
Octreotide acetate
|
[79517-01-4]
[83150-76-9] (net peptide)
|
9750
|
|
[Nal3]Octreotide acetate
|
[848820-27-9] (net peptide)
|
9752
|
|
TETA-Octreotide acetate
|
[226084-96-4] (net peptide)
|
9760
|
|
NOTA-Octreotide trifluoroacetate
|
CAS-RN not yet assigned
|
9762
|
|
NOTA-NOC acetate
|
CAS-RN not yet assigned
|
9765
|
|
Gluc-[Lys0,Lys(ivDde)5]-TOCA
|
CAS-RN not yet assigned
|
9771
|
|
DOTA-TATE acetate (GMP)
|
[177943-89-4]
|
9772
|
|
Ga-DOTA-TATE
|
[777842-51-0]
[293295-75-7] [68Ga]DOTA-TATE
|
9773
|
|
[Tyr3]Octreotate acetate
|
[302794-43-0] (net peptide)
|
9774
|
|
Gluc-Lys(FP)-TOCA
|
CAS-RN not yet assigned
|
9778
|
|
ICG-TATE
|
CAS-RN not yet assigned
|
9782
|
|
Galacto-RGD
|
[922175-70-0] (net peptide)
|
9790
|
|
Fluoropropionyl-Galacto-RGD
|
CAS-RN not yet assigned
|
9800
|
|
NOTA-RGDfK acetate
|
CAS-RN not yet assigned
|
9802
|
|
Ga-NODAGA-RGD dimer
|
CAS-RN not yet assigned
|
9803
|
|
NODAGA-RGD dimer acetate
|
CAS-RN not yet assigned
|
9804
|
|
NODAGA-RGD trifluoroacetate
|
CAS-RN not yet assigned
|
9805
|
|
NODAGA-RGD (GMP)
|
CAS-RN not yet assigned
|
9806
|
|
Ga-NODAGA-RGD
|
CAS-RN not yet assigned
|
9807
|
|
[Tyr3]Octreotide acetate
|
[103667-46-5] (net peptide)
|
9810
|
|
NODAGA-AMBA trifluoroacetate
|
CAS-RN not yet assigned
|
9814
|
|
NOTA-AMBA trifluoroacetate
|
CAS-RN not yet assigned
|
9815
|
|
[Pro1,Tyr4]bombesin (1-14)
|
[832724-21-7] (net peptide)
|
9816
|
|
Lanreotide trifluoroacetate
|
[108736-35-2] (net peptide)
|
9820
|
|
DOTA-Lanreotide acetate
|
[213187-44-1] (net peptide)
|
9831
|
|
HYNIC-Lanreotide trifluoroacetate
|
CAS-RN not yet assigned
|
9836
|
|
4-Formyl-N,N,N-Trimethylanilinium triflate
|
[124915-02-2]
|
9850
|
|
DOTA-NAPamide trifluoroacetate
|
[935886-72-9] (net peptide)
|
9855
|
|
DOTA-Sargastrin
|
CAS-RN not yet assigned
|
9857
|
|
Cyclo-RGDfK
|
[161552-03-0]
|
9860
|
|
Cyclo-RGDfK dimer trifluoroacetate
|
[250612-47-6] (net peptide)
|
9861
|
|
DOTA-RGDfK dimer acetate
|
[250612-06-7] (net peptide)
|
9862
|
|
DOTA-cyclo(RGDfK) acetate
|
[909024-55-1] (net peptide)
|
9863
|
|
HYNIC-cyclo(RGDfK) trifluoroacetate
|
[366455-78-9] (net peptide)
|
9864
|
|
DTPA-Bn-cyclo(RDGfK) dimer trifluoroacetate
|
[1004322-97-7]
|
9866
|
|
HYNIC-cyclo(RGDfK) dimer trifluoroacetate
|
[500166-11-0]
|
9867
|
|
[Tyr3,Lys5(Boc)]octreotide acetate
|
[147790-89-4] (net peptide)
|
9900
|
|
[Lys5(Boc)]octreotate acetate
|
[133304-78-6] (net peptide)
|
9901
|
|
[Lys5(Boc)]lanreotide acetate
|
[182482-12-8] (net peptide)
|
9902
|
|
[Nal3,Lys5(Boc)]octreotide acetate
|
CAS-RN not yet assigned
|
9903
|
|
5(6)-FAM-TATE
|
CAS-RN not yet assigned
|
9908
|
|
PSMA-11 (GMP)
|
[1366302-52-4]
|
9919
|
|
PSMA-11
|
[1366302-52-4]
|
9920
|
|
PSMA-11 (GMP)
|
[1366302-52-4]
|
9921
|
|
GaPSMA-11
|
CAS-RN not yet assigned
|
9922
|
|
PSMA-10
|
CAS-RN not yet assigned
|
9923
|
|
DCFPyL reference standard
|
[1423758-00-2]
|
9925
|
|
PSMA-617
|
CAS-RN not yet assigned
|
9933
|
|
PSMA-617 (GMP)
|
CAS-RN not yet assigned
|
9934
|
|
GaPSMA-617
|
CAS-RN not yet assigned
|
9935
|
|
LuPSMA-617
|
CAS-RN not yet assigned
|
9936
|
|
deprotected DCFPyL precursor
|
CAS-RN not yet assigned
|
9941
|
|
PSMA-1007 precursor
|
CAS-RN not yet assigned
|
9943
|
|
PSMA-1007 reference standard
|
CAS-RN not yet assigned
|
99433
|
|
DOTA-Substance P
|
CAS-RN not yet assigned
|
9960
|
|
DOTA-Substance P
|
CAS-RN not yet assigned
|
9960
|
